Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Subscribe To Our Newsletter & Stay Updated